We assessed whether CR3-deficient NK cells have enhanced tumor cell killing capacity and whether CR3 deficiency and more specifically CR3-deficient NK cells protect mice from pulmonary metastatic melanoma. The gene discussed is CRIPTO3; the disease is neoplasm.